Related Experiment Videos
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation
A Melms1, R Weissert, W E Klinkert
1Max-Planck-Society, Clinical Research Unit for Multiple Sclerosis, Würzburg, Germany.
Neurology
|March 1, 1993
Summary
In myasthenia gravis, anti-acetylcholine receptor (AChR) antibodies can boost T-cell responses when antigen levels are low. This immune complex formation highlights T and B cell interactions in disease exacerbation.
Area of Science:
- Immunology
- Neuroimmunology
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- Acetylcholine receptor (AChR)-specific T-helper cells play a role in MG pathogenesis.
- The interplay between autoantibodies and T-cells in MG requires further elucidation.
Observation:
- Murine monoclonal anti-AChR antibodies were tested against AChR-specific T-helper cells from MG patients.
- At optimal antigen concentrations, anti-AChR antibodies had no significant effect on T-cell responses.
- At substimulatory antigen concentrations, anti-AChR antibodies significantly enhanced T-cell proliferation.
Findings:
- Immune complex formation, facilitated by Fc receptors on antigen-presenting cells, enhances antigen uptake at low antigen levels.
- This mechanism leads to a potent stimulation of AChR-specific T lymphocytes.
- Inhibition of Fc receptors blocked the antigen capture and subsequent T-cell stimulation.
Implications:
- Immune complex-mediated T-cell stimulation may contribute to myasthenia gravis exacerbations.
- This study reveals a critical interaction between T and B lymphocytes in MG.
- Understanding this interaction could lead to novel therapeutic strategies for MG.